[1] [1] OSTERHOLM M T, KELLEY N S, SOMMER A, et al. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis ［J］. The Lancet Infectious Diseases, 2012, 12(1): 36-44.

[3] [3] TOUNEKTI T, JORBERT E, HERNANAEZ I, et al. Improving the polyphenol content of tea ［J］. Critical Reviews in Plant Sciences, 2013, 32(3): 192-215.

[4] [4] LIU J B, LI J L, ZHUANG K, et al. Epigallocatechin-3-gallate local pre-exposure application prevents SHIV rectal infection of macaques ［J］. Mucosal Immunology, 2018, 11(4): 1230-1238.

[5] [5] SHARMA N, MURALI A, SINGH S K, et al. Epigallocatechin gallate, an active green tea compound inhibits the Zika virus entry into host cells via binding the envelope protein ［J］. International Journal of Biological Macromolecules, 2017, 104(Pt A): 1046-1054.

[6] [6] KARAMESE M, AYDOGDU S, KARAMESE S A, et al. Preventive effects of a major component of green tea, epigallocathechin-3-gallate, on hepatitis-B virus DNA replication ［J］. Asian Pacific Journal of Cancer Prevention, 2015, 16(10): 4199-4202.

[7] [7] CHOWDHURY P, SAHUC M E, ROUILLé Y, et al. Theaflavins, polyphenols of black tea, inhibit entry of hepatitis C virus in cell culture ［J］. Public Library of Science One, 2018, 13(11): e0198226.

[8] [8] FUKAZAWA H, SUZUKI T, WAKITA T, et al. A cell-based, microplate colorimetric screen identifies 7, 8-benzoflavone and green tea gallate catechins as inhibitors of the hepatitis C virus ［J］. Biological & Pharmaceutical Bulletin, 2012, 35(8): 1320-1327.

[9] [9] WEBER C, SLIVA K, VON RHEIN C, et al. The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection ［J］. Antiviral Research, 2015, 113: 1-3.

[10] [10] DE OLIVEIRA A, ADAMS S D, LEE L H, et al. Inhibition of herpes simplex virus type 1 with the modified green tea polyphenol palmitoyl-epigallocatechin gallate ［J］. Biological Research Association, 2013, (52): 207-215.

[12] [12] FURUSHIMA D, IDE K, YAMADA H. Effect of tea catechins on influenza infection and the common cold with a focus on epidemiological/clinical studies ［J］. Molecule, 2018, 23(7): 1795.

[13] [13] IDE K, KAWASAKI Y, KAWAKAMI K, et al. Anti-influenza virus effects of catechins: a molecular and clinical review ［J］. Current Medicinal Chemistry, 2016, 23(42): 4773-4783.

[14] [14] WU M, LIU D, ZENG R, et al. Epigallocatechin-3-gallate inhibits adipogenesis through down-regulation of PPARγ and FAS expression mediated by PI3K-AKT signaling in 3T3-L1 cells ［J］. European Journal of Pharmacology, 2017, 795: 134-142.

[15] [15] YANG Z F, BAI L P, HUANG W B, et al. Comparison of in vitro antiviral activity of tea polyphenols against influenza A and B viruses and structure-activity relationship analysis ［J］. Fitoterapia, 2014, 93: 47-53.

[16] [16] SONG J M, LEE K H, SEONG B L. Antiviral effect of catechins in green tea on influenza virus ［J］. Antiviral Research, 2005, 68(2): 66-74.

[18] [18] LING J X, WEI F, LI N, et al. Amelioration of influenza virus-induced reactive oxygen species formation by epigallocatechin gallate derived from green tea ［J］. Acta Pharmacologica Sinica, 2012, 33(12): 1533-1541.

[20] [20] FURUTA T, HIROOKA Y, ABE A, et al. Concise synthesis of dideoxy-epigallocatechin gallate (DO-EGCG) and evaluation of its anti-influenza virus activity ［J］. Bioorganic & Medicinal Chemistry Letters, 2007, 17(11): 3095-3098.

[21] [21] SONG J M, PARK K D, LEE K H, et al. Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives ［J］. Antiviral Research, 2007, 76(2): 178-185.

[22] [22] MORI S, MIYAKE S, KOBE T, et al. Enhanced anti-influenza A virus activity of (-)-epigallocatechin-3-O-gallate fatty acid monoester derivatives: effect of alkyl chain length ［J］. Bioorganic & Medicinal Chemistry Letters, 2008, 18(14): 4249-4252.

[23] [23] MATSUMOTO?Y, KAIHATSU?K, NISHINO?K, et al. Antibacterial and antifungal activities of new acylated derivatives of epigallocatechin gallate ［J］. Frontiers in Microbiology, 2012, 3: 53.

[24] [24] KAIHATSU K, YAMABE M, EBARA Y. Antiviral mechanism of action of epigallocatechin-3-o-gallate and its fatty acid esters ［J］. Molecules, 2018, 23(10): 2475.

[25] [25] SANG S M, LAMBERT J D, TIAN S Y, et al. Enzymatic synthesis of tea theaflavin derivatives and their antiinflammatory and cytotoxic activities ［J］. Bioorganic & Medicinal Chemistry, 2004, 12(2): 459-467.

[26] [26] NAKAYAMA M, TODA M, OKUBO S, et al. Inhibition of influenza virus infection by tea ［J］. Letters in Applied Microbiology, 1990, 11: 38-40.

[27] [27] NAKAYAMA M, SUZUKI K, TODA M, et al. Inhibition of the infectivity of influenza virus by tea polyphenols ［J］. Antiviral Research, 1993, 21(4): 289-299.

[28] [28] NAKAYAMA M, TODA M, OKUBO S, et al. Inhibition of the infectivity of influenza virus by black tea extract ［J］. Kansenshogaku Zasshi, 1994, 68(7): 824-829.

[30] [30] ZU M, YANG F, ZHOU W, et al. In vitro anti-influenza virus and anti-inflammatory activities of theaflavin derivatives ［J］. Antiviral Research, 2012, 94(3): 217-24.

[32] [32] SAHA R K, TAKAHASHI T, KUREBAYASHI Y, et al. Antiviral effect of strictinin on influenza virus replication ［J］. Antiviral Research, 2010, 88(1): 10-18.

[33] [33] CHEN G H, LIN Y L, HSU W L, et al. Significant elevation of antiviral activity of strictinin from Pu’er tea after thermal degradation to ellagic acid and gallic acid ［J］. Journal of Food and Drug Analysis, 2015, 23(1): 116-123.

[34] [34] JARIWALLA R J, ROOMI M W, GANGAPURKAR B, et al. Suppression of influenza A virus nuclear antigen production and neuraminidase activity by a nutrient mixture containing ascorbic acid, green tea extract and amino acids ［J］. Biofactors, 2007, 31(1): 1-15.

[35] [35] SMEE D F, HURST B L, WONG M H. Effects of TheraMax on influenza virus infections in cell culture and in mice ［J］. Antiviral Chemistry & Chemotherapy, 2011, 21(6): 231-237.

[36] [36] COLPITTS C C, SCHANG L M. A small molecule inhibits virion attachment to heparan sulfate- or sialic acid-containing glycans ［J］. Journal of Virology, 2014, 88(14): 7806-7817.

[37] [37] LIU J X, YANG Z W, WANG S Q, et al. Exploring the molecular basis of H5N1 hemagglutinin binding with catechins in green tea: a flexible docking and molecular dynamics study ［J］. Journal of Theoretical & Computational Chemistry, 2012, 11(1): 111-125.

[38] [38] KIM M, KIM S Y, LEE H W, et al. Inhibition of influenza virus internalization by (-)-epigallocatechin-3-gallate ［J］. Antiviral Research, 2013, 100(2): 460-472.

[39] [39] MOSCONA A. Neuraminidase inhibitors for influenza ［J］. The New England Journal of Medicine, 2005, 353(13): 1363-1373.

[40] [40] SAHOO M, JENA L, RATH S N, et al. Identification of suitable natural inhibitor against influenza a (H1N1) neuraminidase protein by molecular docking ［J］. Genomics & Informatics, 2016, 14(3): 96-103.

[41] [41] MüLLER P, DOWNARD K M. Catechin inhibition of influenza neuraminidase and its molecular basis with mass spectrometry ［J］. Journal of Pharmaceutical and Biomedical, 2015, 111: 222-230.

[43] [43] KUZUHARA T, IWAI Y, TAKAHASHI H, et al. Green tea catechins inhibit the endonuclease activity of influenza A virus RNA polymerase ［J］. Public Library of Science Currents, 2009, 1: 1052.

[44] [44] IMANISHI N, TUJI Y, KATADA Y, et al. Additional inhibitory effect of tea extract on the growth of influenza A and B viruses in MDCK cells ［J］. Microbiology Immunology, 2002, 46(7): 491-494.

[46] [46] LEE Y H, JANG Y H, KIM Y S, et al. Evaluation of green tea extract as a safe personal hygiene against viral infections ［J］. Journal of Biological Engineering, 2018, 12: 1.

[47] [47] PARK M, YAMADA H, MATSUSHITA K, et al. Green tea consumption is inversely associated with the incidence of influenza infection among schoolchildren in a tea plantation area of Japan ［J］. Journal of Nutrition, 2011, 141(10): 1862-1870.

[48] [48] ROWE C A, NANTZ M P, BUKOWSKI J F, et al. Specific formulation of Camellia sinensis prevents cold and flu symptoms and enhances gamma, delta T cell function: a randomized, double-blind, placebo-controlled study ［J］. Journal of the American College of Nutrition, 2007, 26(5): 445-452.

[49] [49] MATSUMOTO K, YAMADA H, TAKUMA N, et al. Effects of green tea catechins and theanine on preventing influenza infection among healthcare workers: a randomized controlled trial ［J］. BMC?Complementary and Alternative Medicine, 2011, 11(1): 15.

[50] [50] IWATA M, TODA M, NAKAYAMA M, et al. Prophylactic effect of black tea extract as gargle against influenza ［J］. Kansenshogaku Zasshi, 1997, 71(6): 487-494.

[51] [51] IDE K, YAMADA H, KAWASAKI Y. Effect of gargling with tea and ingredients of tea on the prevention of influenza infection: a meta-analysis ［J］. BioMed Central Public Health, 2016, 16: 396.

[52] [52] SHIN W J, KIM Y K, LEE K H, et al. Evaluation of the antiviral activity of a green tea solution as a hand-wash disinfectant ［J］. Bioscience Biotechnology and Biochemistry, 2012, 76(3): 581-584.

[53] [53] LEE Y H, JANG Y H, BYUN Y H, et al. Green tea catechin-inactivated viral vaccine platform ［J］. Frontiers in Microbiology, 2017, 8: 2469.

[54] [54] WON Y S, KUMAZOE M, TAKAMATSU K, et al. Green tea cultivar ‘Benifuuki’ potentiates split vaccine-induced immunoglobulin A production ［J］. Journal of Natural Medicines, 2017, 71(1): 68-75.

[56] [56] YAMADA H, TAKUMA N, DAIMON T, et al. Gargling with tea catechin extracts for the prevention of influenza infection in elderly nursing home residents: a prospective clinical study ［J］. Journal of Alternative and Complementary Medicine, 2006, 12(7): 669-672.

[57] [57] KUO K L, WENG M S, CHIANG C T, et al. Comparative studies on the hypolipidemic and growth suppressive effects of oolong, black, pu-erh, and green tea leaves in rats ［J］. Journal of Agricultural and Food Chemistry, 2005, 53(2): 480-489.